Cargando…
(125)I-labelled human chorionic gonadotrophin (hCG) as an elimination marker in the evaluation of hCG decline during chemotherapy in patients with testicular cancer
The rate of reduction in the concentration of serum human chorionic gonadotrophin (hCG) following chemotherapy for germ cell tumours may follow a complex pattern, with longer apparent half-life during later stages of chemotherapy, even in patients treated successfully. The commonly used half-life of...
Autores principales: | Christensen, T B, Engbaek, F, Marqversen, J, Nielsen, S I, Kamby, C, Maase, H von der |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363107/ https://www.ncbi.nlm.nih.gov/pubmed/10408402 http://dx.doi.org/10.1038/sj.bjc.6690565 |
Ejemplares similares
-
Validation of (125)I-hCG as a marker for elimination of hCG and stability of (125)I-hCG after in vivo injection in humans
por: Christensen, T B, et al.
Publicado: (1999) -
Biological functions of hCG and hCG-related molecules
por: Cole, Laurence A
Publicado: (2010) -
Rising serum values of beta-subunit human chorionic gonadotrophin (hCG) in patients with progressive vulvar carcinomas.
por: de Bruijn, H. W., et al.
Publicado: (1997) -
Different hCG assays to measure ectopic hCG secretion in bladder carcinoma patients.
por: Mora, J., et al.
Publicado: (1996) -
Human Chorionic Gonadotropin (hCG)—An Endocrine, Regulator of Gestation and Cancer
por: Heidegger, Helene, et al.
Publicado: (2018)